Cargando…
PLDLA/TPU Matrix Enriched with Cyclosporine A as a Therapeutic Platform for Immune-Mediated Keratitis (IMMK) in Horses
The purpose of this study was to describe the use of PLDLA/TPU matrix enriched with cyclosporine A (CsA) as a therapeutic platform in horses with immune-mediated keratitis (IMMK) with an in vitro evaluation CsA release and degradation of the blend as well as determination of the safety and efficacy...
Autores principales: | Padjasek, Martyna, Cisło-Sankowska, Anna, Lis-Bartos, Anna, Qasem, Badr, Marycz, Krzysztof |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057311/ https://www.ncbi.nlm.nih.gov/pubmed/36982806 http://dx.doi.org/10.3390/ijms24065735 |
Ejemplares similares
-
Cyclosporine A Delivery Platform for Veterinary Ophthalmology—A New Concept for Advanced Ophthalmology
por: Padjasek, Martyna, et al.
Publicado: (2022) -
PLDLA/PCL-T Scaffold for Meniscus Tissue Engineering
por: Esposito, Andrea Rodrigues, et al.
Publicado: (2013) -
Treatment of immune-mediated keratitis (IMMK) in dogs with immunosuppressants observed with spectral domain optical coherence tomography (SD-OCT)
por: Kim, Hyelin, et al.
Publicado: (2023) -
A Promising Tool in Retina Regeneration: Current Perspectives and Challenges When Using Mesenchymal Progenitor Stem Cells in Veterinary and Human Ophthalmological Applications
por: Cislo-Pakuluk, Anna, et al.
Publicado: (2017) -
Sex hormone-binding globulin (SHBG) mitigates ER stress and improves viability and insulin sensitivity in adipose-derived mesenchymal stem cells (ASC) of equine metabolic syndrome (EMS)-affected horses
por: Bourebaba, Nabila, et al.
Publicado: (2023)